Efficacy of transarterial therapy combined with first-line tyrosine kinase inhibitors for unresectable hepatocellular carcinoma: a network meta-analysis.

World journal of surgical oncology(2023)

引用 1|浏览1
暂无评分
摘要
HAIC and TACE plus lenvatinib were relatively better choice for unresectable hepatocellular carcinoma. However, owing to the lack of statistically significant OS benefits among most agents, other agents should be considered as potential alternatives for unresectable hepatocellular carcinoma.
更多
查看译文
关键词
Transarterial chemoembolization, Hepatic arterial infusion chemotherapy, Selective internal radiation therapy, Tyrosine kinase inhibitors, Hepatocellular carcinoma, Network meta-analysis
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要